China Slaps $500M Fine on GlaxoSmithKline for Bribery
China has fined British pharmaceutical giant GlaxoSmithKline $491.5 million after a Chinese court found its subsidiary in the country guilty of bribing non-government staff. Chines
Login
X
- New Ventures
- Market Analysis
- Emerging Markets
- Technology
- Professional Services
- Media & Entertainment
- Manufacturing & Retail
- Logistics & Supply Chain
- Healthcare & Pharmaceutical
- Financial Services
- Energy
- Autos
- Aerospace & Defense
- Work-Life Balance
- Strategic Thinking
- Productivity
- Decision Making
- Communication
- Sustainability
- Success Story
- Power Players
- Philanthropy
- People
- Innovation
- CEO Magazine
